Russell Investments Group’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.6K Sell
15,363
-727
-5% -$2.56K ﹤0.01% 3640
2026
Q1
$63.4K Hold
16,090
﹤0.01% 3235
2025
Q4
$127K Sell
16,090
-520
-3% -$4.18K ﹤0.01% 2977
2025
Q3
$134K Sell
16,610
-202
-1% -$1.73K ﹤0.01% 2940
2025
Q2
$106K Sell
16,812
-2,102
-11% -$17.9K ﹤0.01% 2804
2025
Q1
$173K Buy
18,914
+18,685
+8,159% +$71.2K ﹤0.01% 2633
2024
Q4
$536 Sell
229
-966
-81% -$9.39K ﹤0.01% 3598
2024
Q3
$17.4K Buy
+1,195
New +$18.5K ﹤0.01% 2987

Other funds holding CRVO

Russell Investments Group's CRVO Position: Q2 2026 in Review

Russell Investments Group reduced its CervoMed (CRVO) stake by 4.5% in Q2 2026, selling an estimated $2.56K and leaving 15,363 shares worth $47.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3640.

Russell Investments Group first reported a position in CRVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $173K in Q1 2025. 16 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Russell Investments Group held 15,363 shares of CervoMed worth $47.6K as of Q2 2026.
  • Russell Investments Group sold 727 CervoMed shares in Q2 2026, an estimated $2.56K.
  • CervoMed made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3640 holding.
  • Russell Investments Group first reported a position in CervoMed in Q3 2024 and has held it in 8 quarters since.
  • Russell Investments Group's CervoMed position peaked at $173K in Q1 2025.
  • 16 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.